1. F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J. Clin., vol. 68, no. 6, pp. 394–424, Nov. 2018.
2. S. Ades, Adjuvant chemotherapy for colon cancer in the elderly: Moving from evidence to practice, Oncology, 2009.
3. N. F. Jensen et al., Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance, Mol. Oncol., 2015.
4. O. T., G. S., L. J.-B., T. A., M. T., K. M., T. Othman, S. Goto, J. B. Lee, A. Taimura, T. Matsumoto, and M. Kosaka, Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel, Pharmacology, 2001.
5. A. M. Barbuti and Z. S. Chen, Paclitaxel through the ages of anticancer therapy: Exploring its role in chemoresistance and radiation therapy, Cancers. 2015.